Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Angeli

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 2, 2005
How can we use the results of ambulatory blood pressure monitoring in clinical practice?Paolo Verdecchia, Fabio Angeli
Recenti Progressi in Medicina|October 24, 2024
[The delapril-indapamide combination in treatment of arterial hypertension: practical implications in light of the new guidelines.]Paolo Verdecchia, Fabio Angeli
Clinical Therapeutics|June 11, 2004
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or bothPaolo Verdecchia, Fabio Angeli
Hypertension (Dallas, Tex. : 1979)|May 23, 2012
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure?Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|September 25, 2020
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerationsPaolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli
Hypertension (Dallas, Tex. : 1979)|July 20, 2023
It Is Time to Reconsider the Blood Pressure Targets in Patients With Type 2 Diabetes?Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli
American Journal of Hypertension|February 11, 2021
The Link Between Inflammation and Hypertension: Unmasking MediatorsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|August 18, 2022
Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation studyMartina Zappa, Paolo Verdecchia, Fabio Angeli
Journal of Hypertension|May 7, 2020
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirusPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
At the beginning of stiffening: endothelial dysfunction meets "pulsology"Paolo Verdecchia, Fabio Angeli, Stefano Taddei
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Hypertension (Dallas, Tex. : 1979)|June 2, 2005
How can we use the results of ambulatory blood pressure monitoring in clinical practice?Paolo Verdecchia, Fabio Angeli
Recenti Progressi in Medicina|October 24, 2024
[The delapril-indapamide combination in treatment of arterial hypertension: practical implications in light of the new guidelines.]Paolo Verdecchia, Fabio Angeli
Clinical Therapeutics|June 11, 2004
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or bothPaolo Verdecchia, Fabio Angeli
Hypertension (Dallas, Tex. : 1979)|May 23, 2012
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure?Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|September 25, 2020
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerationsPaolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli
Hypertension (Dallas, Tex. : 1979)|July 20, 2023
It Is Time to Reconsider the Blood Pressure Targets in Patients With Type 2 Diabetes?Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli
American Journal of Hypertension|February 11, 2021
The Link Between Inflammation and Hypertension: Unmasking MediatorsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|August 18, 2022
Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation studyMartina Zappa, Paolo Verdecchia, Fabio Angeli
Journal of Hypertension|May 7, 2020
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirusPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
At the beginning of stiffening: endothelial dysfunction meets "pulsology"Paolo Verdecchia, Fabio Angeli, Stefano Taddei
Pageof 32